Circulating Levels of Pro-inflammatory Cytokines in Patients with Nonalcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis

被引:2
作者
Hadinia, Abolghasem [1 ]
Doustimotlagh, Amir Hossein [2 ,3 ]
Goodarzi, Hamed Reza [1 ]
Arya, Arash [4 ]
Jafarinia, Mojtaba [1 ]
机构
[1] Islamic Azad Univ, Marvdasht Branch, Dept Genet, Marvdasht, Iran
[2] Yasuj Univ Med Sci, Fac Med, Cellular & Mol Res Ctr, Yasuj, Iran
[3] Yasuj Univ Med Sci, Fac Med, Dept Clin Biochem, Yasuj, Iran
[4] Yasuj Univ Med Sci, Internal Med, Yasuj, Iran
关键词
Interleukin-1; beta; Interleukin-6; Non-Alcoholic Fatty Liver; Non-Alcoholic Steatohepatitis; Tumor Necrosis Factor-alpha; TUMOR-NECROSIS-FACTOR; INSULIN-RESISTANCE; FACTOR-ALPHA; OXIDATIVE STRESS; FOLLOW-UP; ADIPOKINES; NASH; PROGRESSION;
D O I
10.22034/iji.2019.80284
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
Background: Pro-inflammatory cytokines are associated with systemic inflammatory responses. Objective: To investigate the levels of pro-inflammatory cytokines (IL-1 beta, IL-6, and TNF-alpha) in patients with non-alcoholic fatty liver (NAFL) and non-alcoholic steatohepatitis (NASH) compared to healthy individuals. Methods: This case-control study was conducted on 30 patients with NAFL, 30 patients with NASH, and 30 healthy volunteers. The plasma level of IL-1 beta, IL-6, and TNF-alpha were determined by ELISA, and biochemical parameters were measured using colorimetric methods. Results: IL-1 beta and IL-6 levels were significantly higher in patients with NASH compared with NAFL and control group. However, TNF-alpha levels had no significant variations in NAFL and NASH patients compared to the control group (p=0.903 and p=0.960, respectively). Conclusion: Results showed that the levels of ALT activity and pro-inflammatory cytokines were higher in patients with NASH compared to control and NAFL subjects; Therefore, steatosis and inflammation develop as a result of excessive pro-inflammatory factors in NASH.
引用
收藏
页码:327 / 333
页数:7
相关论文
共 50 条
  • [31] Circulating levels of interleukin-18 in patients with non-alcoholic fatty liver disease
    Tapan, Serkan
    Dogru, Teoman
    Kara, Muammer
    Ercin, C. Nuri
    Kilciler, Guldem
    Genc, Halil
    Sertoglu, Erdim
    Acikel, Cengizhan
    Kilic, Selim
    Karslioglu, Yildirim
    Kurt, Ismail
    Erbil, Mehmet K.
    SCANDINAVIAN JOURNAL OF CLINICAL & LABORATORY INVESTIGATION, 2010, 70 (06) : 399 - 403
  • [32] Role of cytokines and chemokines in non-alcoholic fatty liver disease
    Braunersreuther, Vincent
    Viviani, Giorgio Luciano
    Mach, Francois
    Montecucco, Fabrizio
    WORLD JOURNAL OF GASTROENTEROLOGY, 2012, 18 (08) : 727 - 735
  • [33] Fatty Liver and Non-Alcoholic Steatohepatitis
    Saito, Takafumi
    Misawa, Keiko
    Kawata, Sumio
    INTERNAL MEDICINE, 2007, 46 (02) : 101 - 103
  • [34] Role of Adipokines and Cytokines in Non-alcoholic Fatty Liver Disease
    Abenavoli, Ludovico
    Peta, Valentina
    REVIEWS ON RECENT CLINICAL TRIALS, 2014, 9 (03) : 134 - 140
  • [35] Non-alcoholic fatty liver disease
    Smith, Briohny W.
    Adams, Leon A.
    CRITICAL REVIEWS IN CLINICAL LABORATORY SCIENCES, 2011, 48 (03) : 97 - 113
  • [36] Beneficial effect of omarigliptin on diabetic patients with non-alcoholic fatty liver disease/non-alcoholic steatohepatitis
    Hattori, Sachiko
    Nomoto, Kazuomi
    Suzuki, Tomohiko
    Hayashi, Seishu
    DIABETOLOGY & METABOLIC SYNDROME, 2021, 13 (01)
  • [37] SERUM HOMOCYSTEINE LEVELS IN PATIENTS WITH NON-ALCOHOLIC FATTY LIVER DISEASE
    Cetinkaya, Ali
    Kantarceken, Bulent
    Buyukbese, M. Akif
    Celik, Mustafa
    Tolun, Fatma I.
    EUROPEAN JOURNAL OF GENERAL MEDICINE, 2007, 4 (01): : 19 - 24
  • [38] Non-alcoholic fatty liver disease
    Tuyama, Ana C.
    Chang, Charissa Y.
    JOURNAL OF DIABETES, 2012, 4 (03) : 266 - 280
  • [39] Th17 involvement in nonalcoholic fatty liver disease progression to non-alcoholic steatohepatitis
    Carla Melisa Chackelevicius
    Sabrina Eliana Gambaro
    Claudio Tiribelli
    Natalia Rosso
    World Journal of Gastroenterology, 2016, (41) : 9096 - 9103
  • [40] Non-Alcoholic Fatty Liver Disease (NAFLD) and Non-Alcoholic Steatohepatitis (NASH) in HIV
    Jürgen Kurt Rockstroh
    Current HIV/AIDS Reports, 2017, 14 : 47 - 53